PMC:7105881 / 5559-5853 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"219","span":{"begin":75,"end":80},"obj":"Species"},{"id":"220","span":{"begin":81,"end":85},"obj":"Species"},{"id":"221","span":{"begin":87,"end":96},"obj":"Species"},{"id":"222","span":{"begin":186,"end":194},"obj":"Species"},{"id":"223","span":{"begin":278,"end":282},"obj":"Species"}],"attributes":[{"id":"A219","pred":"tao:has_database_id","subj":"219","obj":"Tax:9606"},{"id":"A220","pred":"tao:has_database_id","subj":"220","obj":"Tax:11118"},{"id":"A221","pred":"tao:has_database_id","subj":"221","obj":"Tax:290028"},{"id":"A222","pred":"tao:has_database_id","subj":"222","obj":"Tax:9606"},{"id":"A223","pred":"tao:has_database_id","subj":"223","obj":"Tax:11118"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Shao et al., 2007; Severance et al., 2008). In contrast to the above three human CoVs, HCoV-HKU1 has around 50% seropositive in healthy individuals and a relatively low exposure rate in children (Lehmann et al., 2008; Severance et al., 2008). Although the prevalence of various CoVs is differen"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T38","span":{"begin":75,"end":80},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T39","span":{"begin":97,"end":100},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T40","span":{"begin":152,"end":153},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Shao et al., 2007; Severance et al., 2008). In contrast to the above three human CoVs, HCoV-HKU1 has around 50% seropositive in healthy individuals and a relatively low exposure rate in children (Lehmann et al., 2008; Severance et al., 2008). Although the prevalence of various CoVs is differen"}

    2_test

    {"project":"2_test","denotations":[{"id":"32265848-17889596-36510972","span":{"begin":13,"end":17},"obj":"17889596"},{"id":"32265848-18945884-36510973","span":{"begin":37,"end":41},"obj":"18945884"},{"id":"32265848-18191362-36510974","span":{"begin":212,"end":216},"obj":"18191362"},{"id":"32265848-18945884-36510975","span":{"begin":236,"end":240},"obj":"18945884"}],"text":"Shao et al., 2007; Severance et al., 2008). In contrast to the above three human CoVs, HCoV-HKU1 has around 50% seropositive in healthy individuals and a relatively low exposure rate in children (Lehmann et al., 2008; Severance et al., 2008). Although the prevalence of various CoVs is differen"}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T36","span":{"begin":44,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Shao et al., 2007; Severance et al., 2008). In contrast to the above three human CoVs, HCoV-HKU1 has around 50% seropositive in healthy individuals and a relatively low exposure rate in children (Lehmann et al., 2008; Severance et al., 2008). Although the prevalence of various CoVs is differen"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T95","span":{"begin":75,"end":80},"obj":"SP_6;NCBITaxon:9606"},{"id":"T96","span":{"begin":136,"end":147},"obj":"NCBITaxon:1"},{"id":"T81631","span":{"begin":75,"end":80},"obj":"SP_6;NCBITaxon:9606"},{"id":"T14986","span":{"begin":136,"end":147},"obj":"NCBITaxon:1"}],"text":"Shao et al., 2007; Severance et al., 2008). In contrast to the above three human CoVs, HCoV-HKU1 has around 50% seropositive in healthy individuals and a relatively low exposure rate in children (Lehmann et al., 2008; Severance et al., 2008). Although the prevalence of various CoVs is differen"}